The rate of effective blood pressure control in Allisartan Isoproxil group was significantly higher than in placebo group at week 4 ( 61.3 % vs 50.0 % , P < 0.05 ) and week 8 ( 67.2 % vs 48.6 % , P < 0.01 ) .